BackGenprex Overview

Genprex Current Assets

Latest current assets for GNPX: $16M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$15.84M
↑ 670.50% YoYΔ $13.79M vs prior year quarter

Peer trimmed avg / median

Loading

Genprex Current Assets History

Loading

Genprex vs. peers: Current Assets Comparison

Loading

Genprex Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Genprex (GNPX) FAQ

As of the most recent data (June 2026), GNPX shows a current assets of $16M. That compares with $2.1M in the prior-year period — up 670.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GNPX's current assets is now $16M (was $2.1M) — a 670.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Genprex is outperforming or lagging.

Tracking GNPX's current assets over time shows whether Genprex is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $2.1M in the prior-year period — up 670.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Genprex's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $16M) with ownership activity and broader fundamentals.

Genprex's current assets is $16M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.